Platinum-resistant Ovarian Cancer

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2014-01-07
Clinical Trial Update: Chemo-immunotherapy (Gemcitabine, Interferon-alpha 2b and p53 SLP) in Patients With Platinum-resistant Ovarian Cancer [Phase 1, Phase 2]
A phase 1/2 trial evaluating a chemo-immunotherapy regimen of gemcitabine, interferon-alpha 2b, and p53 SLP in platinum-resistant recurrent …